Infectious Disease, Allergy, and Immunotherapy Collections

To skip the text and go directly to the objects, CLICK HERE

The museum’s collections contain many objects that document antibody-based methods of preventing, treating, or diagnosing disease, but which have not yet been given their own disease-specific section on this website. This section provides an overview of a few of these other types of vaccines, treatments, and diagnostics.

Be sure to see the full range of these widely varied objects in the attached object records after the essay.

Therapies, Vaccines, and Diagnostics Not Covered in Disease-Specific Website Sections

Numerous serums and antitoxins developed to fight diseases such as scarlet fever, dysentery, and botulism are held by the museum. Other examples include anti-pneumococcic serum to treat pneumonia, anti-meningococcic serum to treat meningitis, and perfringens antitoxin to treat gas gangrene.

Collection of antitoxins and serums

Botulism Antitoxin, F(ab), 1990. Scarlet Fever Streptococcus Antitoxin – Concentrated, ca 1929. Serum Antidysenterique (Anti Dysentery Serum), ca 1900-1920.

The collections also include vaccines against plague, hookworm, and anthrax, recombinant vaccines to prevent hepatitis B, and vaccines intended to prevent cholera.

Collection of vaccines and immunizations

Hookworm Vaccine, New drug limited by Federal Law to investigative use only, 2004. Mulford Southern Brand V23 - Anthrax Spore Vaccine No. 4 - for Immunization of Horses, Mules, Cattle, and Sheep, ca 1957. Recombivax HB, Hepatitis B Vaccine (Recombinant), ca 1988.

Diagnostics that test the body’s immunity to disease are well-represented in the collections. The museum has also collected antibody-based tests that can diagnose whether health risks, such as plague, are present in the environment.

Streptococcus Toxin for Dick Test, ca 1947
- Antigen Rapid Test for Yersinia pestis

Streptococcus Toxin for Dick Test, ca 1947, used to determine susceptibility to scarlet fever. SMART Yersinia pestis Anti F-1 Detection Kit for Environmental Sampling - Antigen Rapid Test for Yersinia pestis, ca 1998, tests for the presence of plague.

Allergy

Mulford Fall Pollen Mixture

Mulford Fall Pollen Mixture - Pollen Extract Made from the Pollens of Ragweed, English Plantain and Lamb's Quarters.

From the 1920s to the 1950s, pharmaceutical companies such as Lederle, H.K. Mulford, Sharpe & Dohme, and Parke, Davis & Co. produced a wide range of products intended to test for, treat, and even prevent allergies to common environmental irritants such as house dust, animal proteins, foods, poison ivy and oak, and an abundant variety of pollens. These products represent the period’s general excitement around the idea that immunizations might be able to prevent a multitude of health problems. The objects also document early research into the part antibodies and immunity play in allergic reactions.

Ivyol - Poison Ivy Extract
Test Board of Dried Proteins

Ivyol - Poison Ivy Extract - for the Prophylaxis of Poison Ivy, Poison Oak, and Poison Sumac Dermatitis, ca 1957. Test Board of Dried Proteins Used for Skin Tests for the Diagnosis of Allergies, ca 1922.

Immunotherapy

Coley's Mixture

Coley's Mixture - A Mixed Culture of Streptococcus Pyogenes and Bacillus Prodigiosus, Parke, Davis and Company, 1898

Early research into immunotherapy and cancer treatment is documented in the museum’s collections. One example is Coley’s Mixture, a bacterial mixture manufactured by Parke, Davis & Co. “for the treatment of malignant neoplasms, particularly sarcoma.” The product was inspired by the work of William B. Coley, who in 1891 provided one of the first proofs of the potential value of immunotherapy when he treated a patient with cancer by causing an infection at the site of the tumor through an injection of streptococcus bacteria.

Some of the collection’s more unusual objects offer insight into a period in American medical research when the potential of immunotherapies was being probed and tested. “Immunogen” treatments for streptococcal arthritis and bee venom solution for diagnosis and treatment of arthritis are just a few examples of such objects in the collections.

Streptococcus Immunogen Arthritis
Lyovac Bee Venom Solution

Streptococcus Immunogen Arthritis - Bacterial Antigen made from 2000 million per cc. hemolytic and non-hemolytic Streptococci isolated from rheumatic cases, ca 1937. Lyovac Bee Venom Solution for Diagnosis and Treatment of Arthritis, ca 1955.

The indications or uses for this product as provided by the manufacturer are:For the diagnosis of sensitization to food, plant, bacterial and other proteins.Currently not on view
Description
The indications or uses for this product as provided by the manufacturer are:
For the diagnosis of sensitization to food, plant, bacterial and other proteins.
Location
Currently not on view
date made
ca 1938
expiration date
1939-06-27
maker
Parke, Davis and Company
ID Number
MG.M-04683
catalog number
M-04683
accession number
147292
The indications or uses for this product as provided by the manufacturer are:Protein Extracts: For the treatment of hay fever caused by ragweed and related generaCurrently not on view
Description
The indications or uses for this product as provided by the manufacturer are:
Protein Extracts: For the treatment of hay fever caused by ragweed and related genera
Location
Currently not on view
date made
ca 1938
expiration date
1938-09-15
maker
Parke, Davis and Company
ID Number
MG.M-04684
accession number
147292
catalog number
M-04684
Currently not on view
Location
Currently not on view
date made
ca 1939
expiration date
1940-02-16
maker
Parke, Davis and Company
ID Number
MG.M-04854
catalog number
M-04854
accession number
154611
The indications or uses for this product as provided by the manufacturer are:A shattered, non-specific protein derived from the ox blood fibrin.
Description
The indications or uses for this product as provided by the manufacturer are:
A shattered, non-specific protein derived from the ox blood fibrin. For use in the treatment of infectious and allergic conditions when an increase in the polymorphonuclear white cells is desired.
A pamphlet provide by the manufacturer indicates that the product is "a new preparation for antigenic stimulation which does not produce untoward reactions." The pamphlet specifies that "a 10% solution is employed for intradermal, intravenous, intramuscular, or subcutaneous injection" and lists a large assortment of conditions for which the preparation is indicateded, including migraines, hay fever, colitis, and ulcer of the eye.
Location
Currently not on view
date made
ca 1939
maker
Parke, Davis and Company
ID Number
MG.M-04857
catalog number
M-04857
accession number
154611
Currently not on view
Location
Currently not on view
date made
ca 1938
maker
Parke, Davis and Company
ID Number
MG.M-04859
catalog number
M-04859
accession number
154611
Currently not on view
Location
Currently not on view
date made
ca 1940
maker
Parke, Davis and Company
ID Number
MG.M-04894.03
catalog number
M-04894.03
accession number
155762
Currently not on view
Location
Currently not on view
date made
ca 1940
maker
Parke, Davis and Company
ID Number
MG.M-04894.04
accession number
155762
catalog number
M-04894.04
Currently not on view
Location
Currently not on view
date made
ca 1941
expiration date
1941-11-05
maker
Parke, Davis and Company
ID Number
MG.M-04978
catalog number
M-04978
accession number
160403
Currently not on view
Location
Currently not on view
date made
ca 1941
expiration date
1942
maker
Parke, Davis and Company
ID Number
MG.M-04983
accession number
160403
catalog number
M-04983
Currently not on view
Location
Currently not on view
date made
ca 1941
1941-09-18
maker
Parke, Davis and Company
ID Number
MG.M-04984
accession number
160403
catalog number
M-04984
The indications or uses for this product as provided on the packaging are:Indicated in all cases of bacillary dysentery including those cases of epidemic jail and asylum dysentery and infant summer diarrhea that are due to infection with the dysentery bacillus.Currently not on vi
Description
The indications or uses for this product as provided on the packaging are:
Indicated in all cases of bacillary dysentery including those cases of epidemic jail and asylum dysentery and infant summer diarrhea that are due to infection with the dysentery bacillus.
Location
Currently not on view
date made
ca 1946
maker
Parke, Davis and Company
ID Number
MG.M-06426
catalog number
M-06426
accession number
173771
Currently not on view
Location
Currently not on view
date made
ca 1949
expiration date
1950
maker
Lederle Laboratories Division, American Cyanimid Company
ID Number
MG.M-06545
catalog number
M-06545
accession number
183169
Currently not on view
Location
Currently not on view
date made
ca 1949
expiration date
1950-02-07
maker
Lederle Laboratories Division, American Cyanimid Company
ID Number
MG.M-06530
catalog number
M-06530
accession number
183169
Currently not on view
Location
Currently not on view
date made
ca 1949
expiration date
1950-01-09
maker
Lederle Laboratories Division, American Cyanimid Company
ID Number
MG.M-06532
catalog number
M-06532
accession number
183169
Currently not on view
Location
Currently not on view
date made
ca 1949
expiration date
1950-06-20
maker
Lederle Laboratories Division, American Cyanimid Company
ID Number
MG.M-06533
catalog number
M-06533
accession number
183169
Currently not on view
Location
Currently not on view
date made
ca 1949
expiration date
1950-06-08
maker
Lederle Laboratories Division, American Cyanimid Company
ID Number
MG.M-06534
catalog number
M-06534
accession number
183169
Currently not on view
Location
Currently not on view
date made
ca 1949
expiration date
1949-12-16
maker
Lederle Laboratories Division, American Cyanimid Company
ID Number
MG.M-06536
catalog number
M-06536
accession number
183169
Currently not on view
Location
Currently not on view
date made
ca 1949
expiration date
1950-10-18
maker
Lederle Laboratories Division, American Cyanimid Company
ID Number
MG.M-06538
catalog number
M-06538
accession number
183169
The case lid is stamped "ANTITOXIN SYRINGE.” The date of April 7, 1891 is stamped on the barrel. This was designed and manufactured by Anton Molinari in Woodbridge, N.J.Ref: Anton Molinari, “Piston for Syringes,” U.S. Patent 449,883 (April 7, 1891).Currently not on view
Description
The case lid is stamped "ANTITOXIN SYRINGE.” The date of April 7, 1891 is stamped on the barrel. This was designed and manufactured by Anton Molinari in Woodbridge, N.J.
Ref: Anton Molinari, “Piston for Syringes,” U.S. Patent 449,883 (April 7, 1891).
Location
Currently not on view
date made
ca 1920
patent date
1891-04-07
ID Number
MG.M-07851
catalog number
M-07851
accession number
223292
Wood chest with latched, hinged lid. Paper label on top of lid. Additional paper label with list of contents of kit adhered to inside of chest lid. Chest contains: one 30 cc. bottle of Physiological Salt Solution, one 30 cc.
Description
Wood chest with latched, hinged lid. Paper label on top of lid. Additional paper label with list of contents of kit adhered to inside of chest lid. Chest contains: one 30 cc. bottle of Physiological Salt Solution, one 30 cc. bottle of Suspension of Sterilized Culture of Typhoid Bacillus, one 10 cc. dropping flask for Typhoid Culture with rubber bulb attached, one 10 cc. dropping flask for Salt Solution with rubber bulb attached, five graduated test tubes (one missing from original count) , one metal test tube holder (which holds six test tubes), three glass droppers (one has rubber bulb attached); one cardboard box with nine small capillary tubes for collecting serum, one needle in glass capillary tube, extra rubber bulbs and rubber stopper. Kit also contains one paper booklet with directions. One newspaper clipping - "Easy Method of Doing Widal's Reaction for Typhoid" / "Early Closure of War Wounds" - ca 1916, found in kit.
In 1896, French physician and bacteriologist Georges Fernand Isidore Widal introduced a blood test for typhoid that still bears his name. Scientists had observed that cholera bacteria would clump together when injected into animals that had been immunized against the disease. This clumping, called agglutination, resulted from the binding of antibodies in the blood serum to the bacterial antigens. The clumps were easily observed through a microscope. Widal devised a practical diagnostic technique for typhoid based on this phenomenon. He mixed a small sample of the patient’s blood serum with a suspension of typhoid bacilli, then used a microscope to examine a drop of the solution. If the cells clumped together, the patient had typhoid antibodies, which indicated either current infection or prior exposure to the disease.
In 1905, bacteriologist John Borden modified the Widal test in a way that freed practicing physicians from their reliance on the services of bacteriological laboratories. By 1912, the Mulford company was advertising a complete test outfit based on his modifications. The kit included a needle and glass capillary tubes for collecting blood from the earlobe, a bottle of salt solution for diluting the sample, a bottle of killed typhoid bacilli suspension, dropper bottles, test tubes, and a rack. The test required no microscope, as the bacterial clumping was visible to the naked eye, appearing as a small white mass at the bottom of the test tube.
date made
after 1905
maker
H. K. Mulford Company
ID Number
MG.M-07860
catalog number
M-07860
accession number
223292
Currently not on view
Location
Currently not on view
date made
ca 1952
expiration date
1952-03-26
maker
Eli Lilly and Company
ID Number
1978.0882.04
accession number
1978.0882
catalog number
1978.0882.04
Currently not on view
Location
Currently not on view
date made
ca 1952
expiration date
1952-06-06
maker
American Cyanamid Company. Lederle Laboratories Division
ID Number
1978.0882.13
accession number
1978.0882
catalog number
1978.0882.13
Currently not on view
Location
Currently not on view
date made
ca 1948
maker
E. R. Squibb and Sons
ID Number
1978.0882.56
accession number
1978.0882
catalog number
1978.0882.56
According to 1940 product literature supplied by Parke, Davis & Company:Immune Globulin (Human) is a sterile, refined and concentrated globulin obtained from human placental blood and tissues.Indications: Prevention and modification of measles in susceptible contacts.
Description
According to 1940 product literature supplied by Parke, Davis & Company:
Immune Globulin (Human) is a sterile, refined and concentrated globulin obtained from human placental blood and tissues.
Indications: Prevention and modification of measles in susceptible contacts. May also be used therapeutically in early stages of the disease.
Dosage: Children under five years exposed less than five days, 2 cc.; more than five days, 4 cc. Children over five years exposed less than 5 days, 4 cc.; more than five days, 4-10 cc. depending on age. Injections should be made intramuscularly. / Packages: Immune Globulin (Human) is supplied in vials of 2 cc. (Bio. 109) and 10 cc. (Bio. 119).
Location
Currently not on view
maker
Parke, Davis and Company
ID Number
1978.0882.58
accession number
1978.0882
catalog number
1978.0882.58

Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.

If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.